Windrem Martha S, Roy Neeta S, Wang Jeremy, Nunes Marta, Benraiss Abdellatif, Goodman Robert, McKhann Guy M, Goldman Steven A
Department of Neurology and Neuroscience, Cornell University Medical College, New York, New York 10021, USA.
J Neurosci Res. 2002 Sep 15;69(6):966-75. doi: 10.1002/jnr.10397.
A distinct population of white matter progenitor cells (WMPCs), competent but not committed to generate oligodendrocytes, remains ubiquitous in the adult human subcortical white matter. These cells are present in both sexes and into senescence and may constitute as much as 4% of the cells of adult human capsular white matter. Transduction of adult human white matter dissociates with plasmids bearing early oligodendrocytic promoters driving fluorescent reporters permits the separation of these cells at high yield and purity, as does separation based on their expression of A2B5 immunoreactivity. Isolates of these cells survive xenograft to lysolecithin-demyelinated brain and migrate rapidly to infiltrate these lesions, without extending into normal white matter. Within several weeks, implanted progenitors mature as oligodendrocytes, and develop myelin-associated antigens. Lentiviral tagging with green fluorescent protein confirmed that A2B5-sorted progenitors develop myelin basic protein expression within regions of demyelination and that they fail to migrate when implanted into normal brain. Adult human white matter progenitor cells can thus disperse widely through regions of experimental demyelination and are able to differentiate as myelinating oligodendrocytes. This being the case, they may constitute appropriate vectors for cell-based remyelination strategies.
一种独特的白质祖细胞(WMPCs)群体,有能力但尚未定向分化为少突胶质细胞,在成人人脑皮质下白质中普遍存在。这些细胞在两性中均有,且持续存在至衰老阶段,在成人人脑被膜下白质细胞中所占比例可达4%。用携带驱动荧光报告基因的早期少突胶质细胞启动子的质粒转导成人白质,可实现这些细胞的高产率和高纯度分离,基于A2B5免疫反应性表达进行分离也能达到同样效果。这些细胞的分离物在异种移植到溶血卵磷脂脱髓鞘脑内后能够存活,并迅速迁移至这些损伤部位浸润,而不会延伸至正常白质。在几周内,植入的祖细胞会成熟为少突胶质细胞,并产生髓鞘相关抗原。用绿色荧光蛋白进行慢病毒标记证实,经A2B5分选的祖细胞在脱髓鞘区域内会表达髓鞘碱性蛋白,且当植入正常脑内时它们不会迁移。因此,成人人脑白质祖细胞能够广泛分散到实验性脱髓鞘区域,并能够分化为形成髓鞘的少突胶质细胞。既然如此,它们可能构成基于细胞的髓鞘再生策略的合适载体。